Accidental or intended radiation exposure in a mass casualty setting presents a serious and ongoing threat. While radioprotective agents can be used with some success when given prior to radiation exposure they are of limited use when used post-exposure. The current proposal prepares the groundwork for a post radiation strategy to protect critical tissues affected by ARS within days after the radiation event has occurred. This approach is based on strong preliminary evidence that stromal/stem cell transplantation provides an effective measure to ameliorate radiation injury. Unlike BMT, the critical difference between the two cell transplantation approaches is that endothelial or mesenchymal stem cell transplantation mediates the recovery of damaged host stem cells via accelerated hematopoiesis or intestinal regeneration or wound healing rather than its replacement with donor derived cells. This provides a novel approach to identify the cellular and molecular mechanisms responsible for radiation mitigation. The ultimate goal of this proposal is to exploit this experimental system to identify the factors and signals elaborated by the stromal cells in the stem cell niche (endothelial, mesenchymal and macrophages) that mediate the regeneration of the irradiated gastrointestinal, hematopoietic or cutaneous system. All four projects of this CMCR are thematically based on this premise and have the following objectives: Define pathophysiologic mechanisms, discovery and validation of molecular targets in ARS , Determine how to accelerate stem cell recovery and regeneration by systemic administration of growth factors in mice, Examine whether repair of the ISC niche by TLR activation and/or stromal cell-based therapies could mitigate ARS in vertebrates (i.e. mice and zebrafish), and Explore the potential of modulators of signal transduction to substitute and amplify signals necessary for stem cell survival and regeneration. Project 1: Stem cell-based therapies for mitigation of radiation-induced gastrointestinal syndrome (RIGS). Project 2: Endothelial cell-derived factors for mitigation of bone marrow syndrome. Project 3: Nanoparticle-based therapies for cutaneous radiation syndrome and Project 4: Mitigation of radiation damage by modulating inflammatory signaling pathways.

Public Health Relevance

The CMCR offers many deliverables, such as, intestinal stem cell growth factor, R-spondin1, TLR agonists, GSK inhibitors, Nanoparticle-NO topical agent for wound healing, and endothelial growth factors for mitigation of ARS. Cell based therapies raise hope as transplantation of bone marrow stromal cells mitigate RIGS, 24 hrs after exposure to 18 Gy whole abdominal irradiation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI091175-04
Application #
8517563
Study Section
Special Emphasis Panel (ZAI1-KS-I (M1))
Program Officer
Macchiarini, Francesca
Project Start
2010-08-01
Project End
2015-07-31
Budget Start
2013-08-01
Budget End
2014-07-31
Support Year
4
Fiscal Year
2013
Total Cost
$2,697,066
Indirect Cost
$751,958
Name
Albert Einstein College of Medicine
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
110521739
City
Bronx
State
NY
Country
United States
Zip Code
10461
Alexeev, Vitali; Lash, Elizabeth; Aguillard, April et al. (2014) Radiation protection of the gastrointestinal tract and growth inhibition of prostate cancer xenografts by a single compound. Mol Cancer Ther 13:2968-77
Almo, Steven C; Guha, Chandan (2014) Considerations for combined immune checkpoint modulation and radiation treatment. Radiat Res 182:230-8
Agoni, Lorenzo; Basu, Indranil; Gupta, Seema et al. (2014) Rigosertib is a more effective radiosensitizer than cisplatin in concurrent chemoradiation treatment of cervical carcinoma, in vitro and in vivo. Int J Radiat Oncol Biol Phys 88:1180-7
Vainshtein, Jeffrey M; Kabarriti, Rafi; Mehta, Keyur J et al. (2014) Bone marrow-derived stromal cell therapy in cirrhosis: clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 89:786-803
Zachman, Derek K; Leon, Ronald P; Das, Prerna et al. (2013) Endothelial cells mitigate DNA damage and promote the regeneration of hematopoietic stem cells after radiation injury. Stem Cell Res 11:1013-21
Saha, Subhrajit; Bhanja, Payel; Liu, Laibin et al. (2012) TLR9 agonist protects mice from radiation-induced gastrointestinal syndrome. PLoS One 7:e29357
Vaitheesvaran, Bhavapriya; Yang, Li; Hartil, Kirsten et al. (2012) Peripheral effects of FAAH deficiency on fuel and energy homeostasis: role of dysregulated lysine acetylation. PLoS One 7:e33717
Yang, Li; Vaitheesvaran, Bhavapriya; Hartil, Kirsten et al. (2011) The fasted/fed mouse metabolic acetylome: N6-acetylation differences suggest acetylation coordinates organ-specific fuel switching. J Proteome Res 10:4134-49
Lv, Haitao; Palacios, Gustavo; Hartil, Kirsten et al. (2011) Advantages of tandem LC-MS for the rapid assessment of tissue-specific metabolic complexity using a pentafluorophenylpropyl stationary phase. J Proteome Res 10:2104-12
Saha, Subhrajit; Bhanja, Payel; Kabarriti, Rafi et al. (2011) Bone marrow stromal cell transplantation mitigates radiation-induced gastrointestinal syndrome in mice. PLoS One 6:e24072